Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertility Preservation | 8 | 2025 | 62 | 3.760 |
Why?
|
| Semen Preservation | 2 | 2025 | 14 | 1.710 |
Why?
|
| Cryopreservation | 6 | 2025 | 74 | 1.460 |
Why?
|
| Ovarian Reserve | 3 | 2023 | 11 | 1.200 |
Why?
|
| Neoplasms | 5 | 2025 | 2852 | 1.010 |
Why?
|
| Infertility, Female | 3 | 2023 | 146 | 0.980 |
Why?
|
| Doxorubicin | 2 | 2023 | 286 | 0.900 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2023 | 43 | 0.890 |
Why?
|
| Spermatozoa | 2 | 2025 | 238 | 0.880 |
Why?
|
| Cancer Survivors | 2 | 2025 | 258 | 0.850 |
Why?
|
| Infertility, Male | 2 | 2022 | 287 | 0.780 |
Why?
|
| Directive Counseling | 1 | 2019 | 23 | 0.610 |
Why?
|
| Counseling | 1 | 2020 | 233 | 0.590 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1302 | 0.530 |
Why?
|
| Fertilization in Vitro | 5 | 2024 | 155 | 0.520 |
Why?
|
| Patient Selection | 1 | 2020 | 711 | 0.510 |
Why?
|
| Ovulation Induction | 4 | 2024 | 39 | 0.480 |
Why?
|
| Preimplantation Diagnosis | 3 | 2014 | 27 | 0.440 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 2581 | 0.390 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 622 | 0.390 |
Why?
|
| Granulosa Cells | 3 | 2022 | 139 | 0.320 |
Why?
|
| Cyclophosphamide | 2 | 2023 | 421 | 0.320 |
Why?
|
| Pregnancy | 14 | 2024 | 7370 | 0.290 |
Why?
|
| Oocytes | 3 | 2019 | 280 | 0.280 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 253 | 0.260 |
Why?
|
| Female | 24 | 2024 | 68275 | 0.250 |
Why?
|
| Sperm Banks | 1 | 2025 | 8 | 0.240 |
Why?
|
| Blastocyst | 2 | 2013 | 75 | 0.240 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2013 | 46 | 0.240 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 22 | 0.240 |
Why?
|
| Uterine Perforation | 1 | 2004 | 1 | 0.230 |
Why?
|
| Hysterosalpingography | 1 | 2004 | 6 | 0.230 |
Why?
|
| Humans | 26 | 2025 | 126679 | 0.220 |
Why?
|
| Chromosomes | 1 | 2004 | 118 | 0.210 |
Why?
|
| Aneuploidy | 1 | 2004 | 139 | 0.210 |
Why?
|
| Methotrexate | 1 | 2005 | 313 | 0.210 |
Why?
|
| Paclitaxel | 1 | 2023 | 128 | 0.200 |
Why?
|
| Endometrial Neoplasms | 2 | 2020 | 107 | 0.190 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 443 | 0.190 |
Why?
|
| Adult | 15 | 2024 | 30379 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2004 | 551 | 0.180 |
Why?
|
| Ovarian Diseases | 1 | 2021 | 24 | 0.180 |
Why?
|
| Young Adult | 4 | 2023 | 9655 | 0.180 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 348 | 0.180 |
Why?
|
| Fertility | 1 | 2023 | 251 | 0.170 |
Why?
|
| Premenopause | 1 | 2020 | 36 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2020 | 38 | 0.170 |
Why?
|
| Uterus | 1 | 2024 | 532 | 0.160 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2020 | 61 | 0.160 |
Why?
|
| Gene Expression | 1 | 2004 | 1482 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2024 | 933 | 0.160 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2020 | 52 | 0.150 |
Why?
|
| Vincristine | 1 | 2020 | 190 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 37 | 0.150 |
Why?
|
| Estrogens | 1 | 2020 | 423 | 0.140 |
Why?
|
| Vaccination | 1 | 2023 | 1004 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 202 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 223 | 0.130 |
Why?
|
| Embryo Transfer | 3 | 2024 | 51 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 443 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 456 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2024 | 16985 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2014 | 50 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 77 | 0.110 |
Why?
|
| Male | 5 | 2025 | 62490 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2004 | 748 | 0.090 |
Why?
|
| Parents | 1 | 2019 | 1072 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3656 | 0.090 |
Why?
|
| Obesity | 1 | 2020 | 2333 | 0.070 |
Why?
|
| Oogenesis | 1 | 2008 | 47 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2008 | 75 | 0.070 |
Why?
|
| Middle Aged | 3 | 2023 | 27672 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 297 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 34 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2024 | 4953 | 0.060 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 133 | 0.060 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 12 | 0.060 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 14 | 0.060 |
Why?
|
| Blastomeres | 1 | 2004 | 6 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 66 | 0.060 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 37 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2005 | 334 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2005 | 619 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 63 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 126 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2004 | 103 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2005 | 223 | 0.050 |
Why?
|
| Live Birth | 1 | 2023 | 66 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 286 | 0.050 |
Why?
|
| ROC Curve | 1 | 2004 | 587 | 0.050 |
Why?
|
| Acceleration | 1 | 2022 | 24 | 0.050 |
Why?
|
| Follicular Fluid | 1 | 2021 | 8 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 442 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2003 | 362 | 0.040 |
Why?
|
| Wound Healing | 1 | 2004 | 447 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 42 | 0.040 |
Why?
|
| Proxy | 1 | 2019 | 21 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2004 | 516 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2019 | 47 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2225 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 422 | 0.030 |
Why?
|
| Endometrium | 1 | 2020 | 264 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3901 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 19987 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1569 | 0.030 |
Why?
|
| Biomarkers | 2 | 2020 | 3219 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1221 | 0.030 |
Why?
|
| Cytokines | 1 | 2021 | 1317 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3311 | 0.030 |
Why?
|
| United States | 2 | 2020 | 11297 | 0.030 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 7 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2013 | 136 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3247 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2004 | 8343 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5113 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 4772 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 841 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10545 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 3545 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 424 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 557 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3262 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 20321 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 5939 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 2591 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 33045 | 0.000 |
Why?
|